National News

Jul 22, 2011 10:46 AM by Lauren Wilson & AP

FDA: 2-fold death increase seen with heart drug

WASHINGTON (AP) - Federal health regulators are warning doctors that a heart drug from Sanofi was associated with fatal heart problems in a recently halted company study.
The Food and Drug Administration reported Thursday that Sanofi halted a trial of its drug Multaq after patients taking the drug showed a two-fold increase in heart attacks, stroke and death compared with patients taking placebo.
The study enrolled patients with a permanent heart condition known as atrial fibrillation which causes the heart's chambers to pump irregularly. The FDA approved the drug in 2009 for a temporary form of the condition. About 241,000 U.S. have received a prescription for the drug.
The FDA said it is still reviewing the trial results and advises patients taking Multaq to talk with their doctor.

»Comments

»Topics in this article

Top Videos

1 2 3 4

Most Popular